PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Global X Genomics & Biotechnology ETF (GNOM)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISINUS37954Y4347
CUSIP37954Y434
IssuerGlobal X
Inception DateApr 5, 2019
RegionNorth America (U.S.)
CategoryHealth & Biotech Equities
Index TrackedSolactive Genomics Index
Home Pagewww.globalxetfs.com
Asset ClassEquity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

The Global X Genomics & Biotechnology ETF has a high expense ratio of 0.50%, indicating higher-than-average management fees.


0.50%1.00%1.50%2.00%0.50%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with GNOM

Global X Genomics & Biotechnology ETF

Popular comparisons: GNOM vs. ARKG, GNOM vs. TMQ, GNOM vs. IBBQ, GNOM vs. IBB, GNOM vs. FXAIX, GNOM vs. IDNA, GNOM vs. VGT, GNOM vs. VOO, GNOM vs. FTEC, GNOM vs. SMH

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Global X Genomics & Biotechnology ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%80.00%OctoberNovemberDecember2024FebruaryMarch
-25.51%
81.72%
GNOM (Global X Genomics & Biotechnology ETF)
Benchmark (^GSPC)

S&P 500

Returns By Period

Global X Genomics & Biotechnology ETF had a return of -1.11% year-to-date (YTD) and -2.56% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-1.11%10.04%
1 month-2.31%3.53%
6 months11.73%22.79%
1 year-2.56%32.16%
5 years (annualized)N/A13.15%
10 years (annualized)N/A10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-6.99%11.44%
2023-8.48%-9.44%-12.98%17.69%10.96%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
GNOM
Global X Genomics & Biotechnology ETF
-0.15
^GSPC
S&P 500
2.76

Sharpe Ratio

The current Global X Genomics & Biotechnology ETF Sharpe ratio is -0.15. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-0.15
2.76
GNOM (Global X Genomics & Biotechnology ETF)
Benchmark (^GSPC)

Dividends

Dividend History

Global X Genomics & Biotechnology ETF granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.


PeriodTTM2023202220212020
Dividend$0.00$0.00$0.00$0.01$0.03

Dividend yield

0.00%0.00%0.00%0.03%0.14%

Monthly Dividends

The table displays the monthly dividend distributions for Global X Genomics & Biotechnology ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.01
2020$0.03

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-59.00%
0
GNOM (Global X Genomics & Biotechnology ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Global X Genomics & Biotechnology ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Global X Genomics & Biotechnology ETF was 68.54%, occurring on Oct 27, 2023. The portfolio has not yet recovered.

The current Global X Genomics & Biotechnology ETF drawdown is 59.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-68.54%Feb 9, 2021685Oct 27, 2023
-35.36%Dec 26, 201957Mar 18, 202042May 18, 202099
-21.6%Apr 11, 2019121Oct 2, 201940Nov 27, 2019161
-14.38%Jul 21, 202035Sep 8, 202021Oct 7, 202056
-9.15%Oct 14, 202013Oct 30, 20208Nov 11, 202021

Volatility

Volatility Chart

The current Global X Genomics & Biotechnology ETF volatility is 6.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%OctoberNovemberDecember2024FebruaryMarch
6.44%
2.82%
GNOM (Global X Genomics & Biotechnology ETF)
Benchmark (^GSPC)